Biosensors International provides innovative and customized medical devices for the growing and increasingly sophisticated practice of medicine worldwide. With R&D, manufacturing and distribution worldwide, Biosensors specializes in the design, research, development and distribution of special diagnostic and therapeutic cardiovascular catheters and interventional cardiology products.

Biosensors' Critical Care Products and Interventional Products bring the latest in technological innovations to medicine at cost-competitive prices, to meet exacting clinical requirements. Together, these two business segments have a market potential of close to US$25 billion by 2010.

Biosensors is a part of holding company Biosensors International Group. Biosensors International Group's goal is to become the top medical device company in Asia specializing in cardiovascular and intervention cardiology products with a global reach.

Today, Biosensors employs more than 200 staff and has offices in Singapore, USA, Japan, Europe and Malaysia.

The group is now planning further expansion, particularly in the Asia-Pacific region, where demand for its products is growing.